Four Undervalued Healthcare Stocks For 2023
Pfizer Inc. could outperform with consistent dividend and revenue growth.Regeneron Pharmaceuticals Inc. has a high P/E with a low upside but value could increase on continued revenue growth.Innoviva Inc. started the year heavily down but strong revenue gains could offset projected losses.Exelixis Inc. is near its 52-week bottom but a furtive P/E and impressive upside could push it to a 52-week high.5 stocks we like better than ExelixisQ4 2022 hedge fund letters, conferences and more Find A Qualified Financial AdvisorEach advisor has been vetted by SmartAsset and is held to a fiduciary standard...